Has Valerie Flores received payments from drug or device companies?

Yes. Drug and device makers reported $183,705 in general payments to Valerie Flores across 263 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Valerie Flores did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Valerie Flores come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Valerie Flores

Reproductive Endocrinology · San Diego, CANPI 1447513908

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $112,795 of the $183,705 with a category attached, or 61.4%. AbbVie accounts for 71.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $90,726 and has fallen 83.0% since, to $15,451 in 2025. Among reproductive endocrinology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$183,705in general payments, 2019–2025

Across 263 payments — averaging $698.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$131K
Sumitomo Pharma America, Inc.$16K
Ferring Pharmaceuticals Inc.$12K
Myovant Sciences Inc.$8K
Pfizer$6K
EMD Serono, Inc.$5K
plus $7K from 10 others

What the payments were for

Consulting fees$31,82117%
Speaking & faculty fees$112,79561%
Travel & lodging$31,66417%
Food & beverage$7,3864%
Education$390%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	187	$131,242
Sumitomo Pharma America, Inc.	25	$15,666
Ferring Pharmaceuticals Inc.	28	$11,810
Myovant Sciences Inc.	2	$7,670
Pfizer	3	$6,253
EMD Serono, Inc.	5	$4,559
Regeneron	2	$2,265
Biohaven Pharmaceuticals, Inc.	1	$2,000
Coopersurgical, Inc.	2	$1,838
Hologic Sales And Service, LLC	1	$147
Ferring Pharmaceuticals AS	1	$127
Organon	2	$50
Bristol Myers Squibb	1	$23
Ferring International Pharmascience Center US	1	$21
Merck	1	$19
Braintree Laboratories, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$183,705 in reported general payments places this provider in the 95th percentile of 230 reproductive endocrinology providers in California.

See all reproductive endocrinology providers in California →

Other reproductive endocrinology in San Diego

Louis KettelSan Diego$8K
Steven BrodySan Diego$3K
Hui Chun SuSan Diego$3K
Arlene MoralesSan Diego$3K
Wendy ShellySan Diego$2K
Bryn WillsonSan Diego$2K
Sharon WinerBeverly Hills$449K
Sanjay Agarwalla Jolla$262K
Monica PasternakSan Francisco$77K
Linda GiudiceSan Francisco$67K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →